UA95930C2 - Інгібітори цистеїнпротеаз, фармацевтична композиція, яка їх містить, та їх терапевтичне застосування - Google Patents

Інгібітори цистеїнпротеаз, фармацевтична композиція, яка їх містить, та їх терапевтичне застосування

Info

Publication number
UA95930C2
UA95930C2 UAA200807680A UAA200807680A UA95930C2 UA 95930 C2 UA95930 C2 UA 95930C2 UA A200807680 A UAA200807680 A UA A200807680A UA A200807680 A UAA200807680 A UA A200807680A UA 95930 C2 UA95930 C2 UA 95930C2
Authority
UA
Ukraine
Prior art keywords
inhibitors
pharmaceutical compositions
therapeutic applications
cysteine proteases
proteases
Prior art date
Application number
UAA200807680A
Other languages
English (en)
Russian (ru)
Inventor
Філіпп Гюдо
Гійом Буассі
Катрін Бор-Капра
Фредерік Коллан
Лоран Дав'є
Етьєнн Формстеше
Ксав'є Жак
Жан-Крістоф Рен
Ремі Делансорн
Іларія Перетто
Стефано Віньяндо
Original Assignee
Ібріженікс Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/296,564 external-priority patent/US7462615B2/en
Application filed by Ібріженікс Са filed Critical Ібріженікс Са
Priority claimed from PCT/IB2006/003475 external-priority patent/WO2007066200A2/en
Publication of UA95930C2 publication Critical patent/UA95930C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Цей винахід стосується нових сполук формули (І), способів їх отримання та їх терапевтичного застосування. EMBED ISISServer (I)
UAA200807680A 2005-12-08 2006-12-05 Інгібітори цистеїнпротеаз, фармацевтична композиція, яка їх містить, та їх терапевтичне застосування UA95930C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05292612A EP1798232A1 (en) 2005-12-08 2005-12-08 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US11/296,564 US7462615B2 (en) 2005-12-08 2005-12-08 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
PCT/IB2006/003475 WO2007066200A2 (en) 2005-12-08 2006-12-05 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications

Publications (1)

Publication Number Publication Date
UA95930C2 true UA95930C2 (uk) 2011-09-26

Family

ID=36282596

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200807680A UA95930C2 (uk) 2005-12-08 2006-12-05 Інгібітори цистеїнпротеаз, фармацевтична композиція, яка їх містить, та їх терапевтичне застосування

Country Status (4)

Country Link
US (1) US20090181972A1 (uk)
EP (1) EP1798232A1 (uk)
CN (1) CN101365702B (uk)
UA (1) UA95930C2 (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236798B2 (en) * 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
CN105327350A (zh) * 2014-07-23 2016-02-17 中国科学院上海巴斯德研究所 泛素化途径相关因子在调控辅助性t细胞功能中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405619A (en) * 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
FR2722789B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
DE19725508A1 (de) 1997-06-17 1998-12-24 Clariant Gmbh Wasch- und Reinigungsmittel
JP2002539162A (ja) * 1999-03-12 2002-11-19 アベンテイス・フアルマ・ソシエテ・アノニム リルゾールおよびａｍｐａ受容体アンタゴニストの組み合わせ剤を用いる筋萎縮性側索硬化症の治療
AU2001240021A1 (en) 2000-04-13 2001-10-30 Millennium Pharmaceuticals, Inc. Diazafluorenone il-8 receptor antagonists
US6514972B2 (en) * 2000-07-06 2003-02-04 Kinetek Pharmaceuticals, Inc. Heteropolycyclic inhibitors of protein kinases

Also Published As

Publication number Publication date
CN101365702B (zh) 2013-03-20
CN101365702A (zh) 2009-02-11
EP1798232A1 (en) 2007-06-20
US20090181972A1 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
MX2009000884A (es) Derivados de piridizinona.
SE0301700D0 (sv) Novel compounds
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
EA201070247A1 (ru) Ингибиторы протеасом
TW200800999A (en) Novel compounds
TW200738659A (en) Novel compounds
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
TW200745122A (en) New compounds I
MX2009008925A (es) Compuestos de la formula (i) como inhibidores de proteasa de serina.
TW200736227A (en) New compounds III
TW200616977A (en) Enantiomers of selected fused heterocyclics and uses thereof
UA96269C2 (uk) Інгібітори цистеїнпротеази та їх терапевтичне застосування
TW200621260A (en) Selected fused heterocyclics and uses thereof
TW200624429A (en) Novel cysteine protease inhibitors
UA106200C2 (uk) Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину
TW200745133A (en) New compounds II
WO2007025776A3 (en) Cysteine protease inhibitors
MX2008007195A (es) Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.
UA95930C2 (uk) Інгібітори цистеїнпротеаз, фармацевтична композиція, яка їх містить, та їх терапевтичне застосування
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
MX2009004517A (es) Nuevos inhibidores tetraciclicos de las proteasas de cisteina, las composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.